Trial
NCT04344873
Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
National Institute on Aging (NIA)
Condition
Cardiovascular Diseases
Intervention
Placebo
Why stopped
COVID initially delayed plans to begin recruitment of subjects. Subsequently, the departure of a clinical investigator and loss of access to equipment and study subject population resulted in study termination before any subjects were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-12